Director Lucas Svetlana made two open market purchases of Jasper Therapeutics ($JSPR) shares in the past year, totaling $48,600, with the most recent on September 22, 2025. This ranks her 3,077th among 4,983 insiders by purchase value, well below the average of $1.46 million across 3.29 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Jasper Therapeutics, Inc. | $JSPR | Lucas Svetlana | Director | P | Voting Common Stock | 20000 | $2.43 | 20,000.0000 | 15,333,962 | 9999.99% | 0.13% |
| Sept. 22, 2025 | Jasper Therapeutics, Inc. | $JSPR | Lucas Svetlana | Director | P | Common Stock Warrant (right to buy) | 20000 | $0.00 | 20,000.0000 | 15,333,962 | 9999.99% | 0.13% |
| July 3, 2025 | Jasper Therapeutics, Inc. | $JSPR | Lucas Svetlana | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| May 1, 2025 | aTYR PHARMA INC | $ATYR | Lucas Svetlana | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 88,858,612 | 9999.99% | 0.06% |
| June 18, 2024 | Jasper Therapeutics, Inc. | $JSPR | Lucas Svetlana | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 13,334,900 | 9999.99% | 0.11% |
| May 22, 2024 | aTYR PHARMA INC | $ATYR | Lucas Svetlana | Not found | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |